Granulocyte colony-stimulating factor was used in 2 patients with neutropenia (1 patient with Grade 3 and 1 patient with Grade 4 neutrophil count decreased), and zandelisib was interrupted in only 1 patient. This evidence concerns the gene CSF3 and Decreased total neutrophil count.